The article also contains recommendations for future trials which will ultimately result in demonstrating the scientific utility of the referenced minimally invasive techniques. ‘These areas of cancer molecular diagnostics have been promising for quite a while,’ said senior writer, Christopher D. Gocke, MD, Johns Hopkins University. ‘We hope that researchers will take this review of circulating tumor nucleic acids and circulating tumor cells as a spur to accomplish the large studies had a need to drive the technology across the finish line. This would be a earn for the field, for our patients, and for the idea of precision medicine.’ Even though many of the studies referenced were smaller and examined only one or a few markers, progress was already made in testing solutions to increase validity and accuracy of samples.Because the 52-bp deletion in Patient H_0191 was incorrectly annotated as a 1-bp deletion coupled with an individual nucleotide variant by our variant-calling analysis pipeline , we manually examined the sequence alignment because of this patient. We observed a misalignment of the sequence reads covering the site of mutation, due to a repetitive aspect in the affected genomic area . Following through to this finding, all of us investigated the alignments for the remaining four individuals and detected a recurrent 5-bp insertion in all 4 . The mutations in CALR which were found by means of whole-exome sequencing had been confirmed and been shown to be somatic through Sanger sequencing of the granulocyte and matched T-lymphocyte DNA samples from all six sufferers.